Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety、Immunogenicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06652737
What this trial is testing

Age De-escalation Safety Trial of PfSPZ-LARC2 Vaccine in Burkina Faso

Who this might be right for
Malaria FalciparumMalaria Infection
Sanaria Inc. 75
Large-scale testing (Phase 3)Study completedNCT05876351
What this trial is testing

Eculizumab in Pediatric and Adult Participants With Atypical Hemolytic Uremic Syndrome (aHUS) in China

Who this might be right for
Atypical Hemolytic Uremic
Alexion Pharmaceuticals, Inc. 25
Large-scale testing (Phase 3)Study completedNCT00968539
What this trial is testing

Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults

Who this might be right for
Influenza
GlaxoSmithKline 130
Large-scale testing (Phase 3)Study completedNCT01041573
What this trial is testing

Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population

Who this might be right for
Encephalitis
Valneva Austria GmbH 1,869
Post-approval studies (Phase 4)Study completedNCT01031069
What this trial is testing

Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 873
Early research (Phase 1)Study completedNCT05559983
What this trial is testing

Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults

Who this might be right for
Cholera Vaccination Reaction
International Vaccine Institute 150
Early research (Phase 1)Study completedNCT04528641
What this trial is testing

Phase I Study to Assess the Safety and Immunology of a COVID-19 Vaccine With GRAd-COV2 Vaccine

Who this might be right for
COVID-19
ReiThera Srl 98
Testing effectiveness (Phase 2)WithdrawnNCT00964951
What this trial is testing

CSL H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT04445831
What this trial is testing

Evaluate the Safety, Tolerability and Immunogenicity of Tau Targeted Vaccines in Participants With Early Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseCognitive ImpairmentTauopathies+4 more
AC Immune SA 57
Testing effectiveness (Phase 2)Study completedNCT02690181
What this trial is testing

Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects.

Who this might be right for
Bacterial Infection Due to Streptococcus, Group BStreptococcus Agalactiae
GlaxoSmithKline 80
Testing effectiveness (Phase 2)UnknownNCT04983537
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Population

Who this might be right for
COVID-19 Vaccines
Ministerio de Salud de Ciudad Autónoma de Buenos Aires 120
Early research (Phase 1)Study completedNCT04100772
What this trial is testing

Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above

Who this might be right for
Pneumococcal InfectionsStreptococcal InfectionsBacterial Infections
CanSino Biologics Inc. 237
Early research (Phase 1)UnknownNCT06627257
What this trial is testing

Trial LEP-F1 + GLA-SE in Healthy Adult in Areas Endemic for Leprosy

Who this might be right for
Leprosy
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 54
Early research (Phase 1)Study completedNCT02066428
What this trial is testing

A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS-404 Administered as Different Amounts of Antigen and Adjuvant Combinations in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection

Who this might be right for
Tuberculosis
Aeras 64
Testing effectiveness (Phase 2)Study completedNCT01198366
What this trial is testing

Study of AERAS-402 in Healthy Infants

Who this might be right for
Tuberculosis
Aeras 487
Early research (Phase 1)Looking for participantsNCT07381829
What this trial is testing

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer

Who this might be right for
Advanced Solid Tumor Cancer
HC Biopharma Inc. 328
Testing effectiveness (Phase 2)Study completedNCT03707353
What this trial is testing

An Efficacy Study of IV Boosting With ChAd63/MVA ME-TRAP

Who this might be right for
Malaria
University of Oxford 43
Early research (Phase 1)Study completedNCT00427453
What this trial is testing

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously

Who this might be right for
Tuberculosis
University of Oxford 12
Testing effectiveness (Phase 2)Study completedNCT02222545
What this trial is testing

Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies

Who this might be right for
Thrombotic Microangiopathies
Omeros Corporation 58
Early research (Phase 1)Study completedNCT03446053
What this trial is testing

Evaluate the Safety, PK, PD, Immunogenicity of N-Rephasin® SAL200 in Healthy Male Volunteers

Who this might be right for
Healthy VolunteersAnti-Bacterial AgentsMethicillin-Resistant Staphylococcus Aureus+1 more
Intron Biotechnology, Inc. 33
Next Page